FR2686513B1 - Compositions pharmaceutiques aqueuses de cromoglycate sodique. - Google Patents

Compositions pharmaceutiques aqueuses de cromoglycate sodique.

Info

Publication number
FR2686513B1
FR2686513B1 FR9302655A FR9302655A FR2686513B1 FR 2686513 B1 FR2686513 B1 FR 2686513B1 FR 9302655 A FR9302655 A FR 9302655A FR 9302655 A FR9302655 A FR 9302655A FR 2686513 B1 FR2686513 B1 FR 2686513B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
aqueous pharmaceutical
sodium cromoglycate
cromoglycate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9302655A
Other languages
English (en)
Other versions
FR2686513A1 (fr
Inventor
James Baskeyfied Lewis
Frederick Jay Graham
Paul Probert Steven
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10718322&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2686513(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of FR2686513A1 publication Critical patent/FR2686513A1/fr
Application granted granted Critical
Publication of FR2686513B1 publication Critical patent/FR2686513B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR9302655A 1992-07-07 1993-03-08 Compositions pharmaceutiques aqueuses de cromoglycate sodique. Expired - Fee Related FR2686513B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929214390A GB9214390D0 (en) 1992-07-07 1992-07-07 Formulations

Publications (2)

Publication Number Publication Date
FR2686513A1 FR2686513A1 (fr) 1993-07-30
FR2686513B1 true FR2686513B1 (fr) 1995-05-24

Family

ID=10718322

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9302655A Expired - Fee Related FR2686513B1 (fr) 1992-07-07 1993-03-08 Compositions pharmaceutiques aqueuses de cromoglycate sodique.

Country Status (12)

Country Link
US (1) US5475023A (fr)
EP (1) EP0587264B1 (fr)
JP (1) JP2916340B2 (fr)
BE (1) BE1005196A0 (fr)
CA (1) CA2090911C (fr)
DE (1) DE69300017T2 (fr)
DK (1) DK0587264T3 (fr)
FR (1) FR2686513B1 (fr)
GB (1) GB9214390D0 (fr)
IE (1) IE64551B1 (fr)
IT (1) ITMI20011389A1 (fr)
NO (1) NO302398B1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5532270A (en) * 1995-04-03 1996-07-02 Ascent Pharmaceuticals, Inc. Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions
US5576346A (en) * 1995-04-03 1996-11-19 Ascent Pharmaceuticals, Inc. Process for treating uremic pruritus
US5552436A (en) * 1995-04-03 1996-09-03 Ascent Pharmaceuticals, Inc. Process for treating hemangioma
EP1421940A4 (fr) * 2001-08-09 2006-02-08 Sekisui Chemical Co Ltd Composition medicale a usage externe destinee au traitement des dermatoses
US6596284B1 (en) 2002-04-30 2003-07-22 Thomas E. Fleming Treating eczema with a combination of isotonic saline ocean® and nasal mast cell stabilizers
EP2248517B1 (fr) * 2009-05-08 2014-03-26 PARI Pharma GmbH Formules pharmaceutiques à stabilisation de membrane concentrée
DK3104854T3 (da) 2014-02-10 2020-05-04 Respivant Sciences Gmbh Mast-celle-stabilisatorer til lungesygdomsbehandling
CN106456595A (zh) 2014-02-10 2017-02-22 帕塔拉制药有限责任公司 用于***性病症的肥大细胞稳定剂治疗
WO2017027402A1 (fr) 2015-08-07 2017-02-16 Patara Pharma, LLC Méthodes de traitement de troubles systémiques aptes à être traités par des stabilisateurs de mastocytes, y compris de troubles liés aux mastocytes
EP3331522A1 (fr) 2015-08-07 2018-06-13 Patara Pharma LLC Méthodes de traitement de troubles liés aux mastocytes par des stabilisateurs de mastocytes
AU2017321495A1 (en) 2016-08-31 2019-03-21 Respivant Sciences Gmbh Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
JP2019531308A (ja) 2016-10-07 2019-10-31 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 肺線維症の治療のためのクロモリン組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US3975536A (en) * 1971-05-12 1976-08-17 Fisons Limited Composition
GB1473318A (en) * 1973-05-25 1977-05-11 Fisons Ltd Solution of 1,3-bis-2-carboxychromon-5-yloxy-propan-2-ol or salts thereof
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
JPH0218393A (ja) * 1988-07-06 1990-01-22 Nitto Chem Ind Co Ltd 人工水晶の製造方法
WO1990013284A1 (fr) * 1989-04-29 1990-11-15 Fisons Plc Composition pharmaceutique contenant du chromoglycate
EP0413583A3 (en) * 1989-08-18 1991-07-17 Dey Laboratories; Inc. Clear, stable cromolyn formulation

Also Published As

Publication number Publication date
DK0587264T3 (da) 1995-03-06
DE69300017T2 (de) 1995-03-30
DE69300017D1 (de) 1994-12-01
EP0587264A1 (fr) 1994-03-16
BE1005196A0 (fr) 1993-05-18
NO302398B1 (no) 1998-03-02
FR2686513A1 (fr) 1993-07-30
JPH0672869A (ja) 1994-03-15
US5475023A (en) 1995-12-12
ITMI20011389A0 (it) 2001-06-29
IE930148A1 (en) 1994-01-12
NO930781D0 (no) 1993-03-03
CA2090911C (fr) 2004-05-18
ITMI20011389A1 (it) 2002-12-29
CA2090911A1 (fr) 1994-01-08
IE64551B1 (en) 1995-08-23
GB9214390D0 (en) 1992-08-19
JP2916340B2 (ja) 1999-07-05
EP0587264B1 (fr) 1994-10-26
NO930781L (no) 1994-01-10

Similar Documents

Publication Publication Date Title
FI970825A (fi) Farmaseuttiset koostumukset, jotka aktiivisen yhdisteen biologisen hyötyosuuden lisäämiseksi sisältävät sappisuolaa ja puskuria
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
FR2636532B1 (fr) Compositions pharmaceutiques
EE03426B1 (et) Risperidooni vesilahuselised ravimvormid
NO904604D0 (no) Fremgangsmaate for fremstilling av natriumsilikater.
FI925615A0 (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en hmg-coa-reduktas-inhibitorfoerening
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
NO953367L (no) Anvendelse av substituerte 4-fenyl-6-amino-nikotinsyre-derivater som legemidler
IT8423263A0 (it) Formulazioni farmaceutiche acquose di piroxicam monoidrato.
FR2686513B1 (fr) Compositions pharmaceutiques aqueuses de cromoglycate sodique.
DZ1559A1 (fr) Compositions pharmaceutiques.
BR9610530A (pt) Derivados de acriloilguanidina substituíduo com heteroarila e composiç es farmacêuticas contendo os mesmos
DE69621039D1 (de) Wässrige silikat-zusammensetzungen
MX9205003A (es) Derivados novedosos de benzopirano.
MC1878A1 (fr) Compositions pharmaceutiques
NO961797D0 (no) Anvendelse av benzopyranderivater for fremstilling av farmasöytiske sammensetninger beregnet for behandling av patologier forbundet med den Na+-uavhengige C1-HCO3-utbytter
DE69307306D1 (de) Wässrige überzugszusammensetzungen
MX9204370A (es) Derivados de pirazol.
NO905327D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamoylderivater.
BR9307182A (pt) Composições farmacêuticas de 2-oxindol-1-carboxamidas 3-substituídas
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
MX9205973A (es) Derivados de benzo-isoquinolinas.
MX9201931A (es) Nuevos derivados de tiazol.
GB2262448B (en) Aqueous pharmaceutical formulations of sodium cromoglycate

Legal Events

Date Code Title Description
ST Notification of lapse